April 2023 in “Jordan Medical Journal” Men with male pattern baldness are more likely to have benign prostatic hyperplasia.
January 2023 in “Türkiye klinikleri adli tıp ve adli bilimler dergisi” DNA markers can help predict male pattern baldness, useful in criminal and missing person cases.
The document is about planning a review to assess if PRP alone is effective for treating hair loss in men and women.
April 2021 in “Journal of Investigative Dermatology” A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.
January 2021 in “Hair therapy & transplantation” Combining PRF and PDO threads shows promise in treating male pattern baldness.
71 genetic markers explain 38% of male-pattern baldness risk.
April 2020 in “Journal of the Endocrine Society” Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.
Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.
January 2018 in “프로그램북(구 초록집)” Botulinum toxin type A is a safe and effective treatment for male pattern baldness.
August 2016 in “Journal of Investigative Dermatology” Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.
November 2015 in “Hair transplant forum international” PRP may help with hair regrowth in male pattern baldness, but more research is needed.
August 2013 in “Hospital Pharmacy” Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.
Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.
April 2012 in “The Journal of Urology” Male pattern baldness may predict prostate cancer risk.
Targeting a specific lipid could help treat male pattern baldness.
January 2012 in “Chinese Journal of Aesthetic Medicine” Increased androgen receptor expression in certain hair follicle areas may cause male pattern baldness.
September 2011 in “Hair transplant forum international” Hair transplants can be effective for early male pattern baldness.
Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.
January 2009 in “Revista de Ciências Médicas” Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.
January 2007 in “Annals of The Royal College of Surgeons of England” Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.
January 2007 in “Inpharma Weekly” Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.
May 2004 in “Dermatologic Surgery” Most men stopped using finasteride for baldness due to unsatisfactory results or were lost to follow-up, and those who continued saw minimal to moderate improvement.
December 2002 in “International Journal of Cosmetic Surgery and Aesthetic Dermatology” No significant link was found between male pattern baldness and Pityrosporum fungi.
January 2001 in “Chinese Journal of Medical Aesthetics and Cosmetology” Micrografts can grow natural hair and most patients are satisfied, but some need multiple procedures.
Minoxidil (Rogaine) increased interest in treating male pattern baldness.
Surgical treatments like hair transplants can help with male pattern baldness.
February 2023 in “Cureus” Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.
August 2021 in “Journal of The American Academy of Dermatology” Finasteride treatment changes hormone levels in male pattern baldness patients.
March 2020 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride treatment changes certain urine metabolites in male pattern baldness patients.
February 2020 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride treatment changes urine metabolites in male pattern baldness patients.